Trial Profile
Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Angina pectoris; Myocardial infarction; Stent thrombosis
- Focus Pharmacodynamics
- Acronyms MATTIS-D
- 23 Jul 2012 New trial record